Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form

Stephen J. Schuster, MD Physician

Director, Lymphoma Program
Director, Lymphoma Translational Research
Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Schuster is a Penn Medicine employed physician.

About Dr. Stephen J. Schuster

Recognized in Philadelphia Magazine's annual Top Docs issue, 2002, and 2010 - 2016

Recognized by America's Top Doctors 2011-14

Recognized by Best Doctors in America 2005-2006, 2011-2012

Clinical Specialties


  • Medicine
    • Hematology
    • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1989

Clinical Expertise:

  • Lymphoma

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital
Fellowship: Pennsylvania Hospital


American Society of Clinical Oncology, National American Society of Hematology, National Eastern Cooperative Oncology Group (ECOG), National Leukemia & Lymphoma Society, National

Hospital Affiliation

Dr. Schuster is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Ruella, Marco. Kenderian, Saad S. Shestova, Olga. Fraietta, Joseph A. Qayyum, Sohail. Zhang, Qian. Maus, Marcela V. Liu, Xiaobin. Nunez-Cruz, Selene. Klichinsky, Michael. Kawalekar, Omkar U. Milone, Michael. Lacey, Simon F. Mato, Anthony. Schuster, Stephen J. Kalos, Michael. June, Carl H. Gill1, Saar. Wasik, Mariusz A.: The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research. 22 (11): 2684-96,2016.

Williams, Michael E. Hong, Fangxin. Gascoyne, Randy D. Wagner, Lynne I. Krauss, John C. Habermann, Thomas M. Swinnen, Lode J. Schuster, Stephen J. Peterson, Christopher G. Sborov, Mark D. Martin, Eric. Weiss, Matthias. Ehmann, W. Christopher. Horning, Sandra J. Kahl, Brad S.: Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Haematology. : 2016.

Yam, Clinton. Landsburg, Daniel J. Lin, Xinyi. Mato, Anthony. Svoboda, Jakub. Loren, Alison. Frey, Noelle. Stadtmauer, Edward A. Porter, David. Schuster, Stephen J. Nasta, Sunita D.: Autologous stem cell transplantation in first complete remission may not extend progression free survival in patients with peripheral T cell lymphomas. American Journal of Hematology. : 2016.

Ruan, Jia. Martin, Peter. Shah, Bijal. Schuster, Stephen J. Smith, Sonali M. Furman, Richard R. Christos, Paul. Rodriguez, Amelyn. Svoboda, Jakub. Lewis, Jessica. Katz, Orel. Coleman, Morton. Leonard, John P.: Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma. The New England Journal of Medicine. 373 (18): 1835-44,2015.

Luskin, Marlise R. Heil, DS. Tan, KS. Choi, Sarah. Stadtmauer, Edward A. Schuster, Stephen J. Porter, David L. Vonderheide, Robert H. Bagg, Adam. Heitjan, Daniel F. Tsai, Donald E. Reshef, Ran.: The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American Joural of Transplant. 15 (10): 2665-73,2015.

Paul, Thomas M. Liu, Stephen V. Chong, Elise A. Luger, Selina M. Porter, David L. Schuster, Stephen J. Tsai, Donald E. Nasta, Sunita D. Loren, Alison. Frey, Noelle. Perl, Alexander. Cohen, Adam D. Weiss, Brendan M. Stadtmauer, Edward A. Vogl, Dan T.: Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma. Clinical Lymphoma Myeloma and Leukemia. 15 (9): 536-40,2015.

Huntington, Scott F. Nasta, Sunita D. Schuster, Stephen J. Doshi, Jalpa A. Svoboda, Jakub.: Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma. 56 (9): 2579-84,2015.

Howlett, Christina. Snedecor, Sonya J. Landsburg, Daniel J. Svoboda, Jakub. Chong, Elis A. Schuster, Stephen J. Nasta, Sunita D. Feldman, Tatyana. Rago, Allison. Walsh, Kristy M. Weber, Scott. Goy, Andre. Mato, Anthony.: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. British Journal of Haematology. 170 (4): 504-14,2015.

Mato, Anthony R. Foon, Kenneth A. Feldman, Tatyana. Schuster, Stephen J. Svoboda, Jakub. Chow, Kar Fai. Valentinetti, Marisa. Mrkulic, Mary. Azzollini, Kelly. Gadaleta, Gabriella. Bhattacharyya, Pritish K. Zenreich, Joshua. Pascual, Lauren-Nicole. Yannotti, Kara. Kdiry, Sabrina. Howlett, Christina. Strelec, Lauren. Porter, David. Bejot, Coleen. Goy, André.: Reduced-dose fludarabine, cyclophosphamide and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology. 90 (6): 487-92,2015.

Chong, Elise A. Ahmadi, Tahamtan. Aqui, Nicole A. Svoboda, Jakub. Nasta, Sunita D. Mato, Anthony R. Walsh, Kristy M. Schuster, Stephen J.: Combination of lenalidomide and rituximab overcomes rituximab-resistance in patients with indolent B-cell and mantle cell lymphomas. Clinical Cancer Research. 21 (8): 1835-42,2015.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1846
Fax: (215) 615-5888
Patient appointments: 800-789-PENN (7366)

Related Links